Capula Management LTD Tg Therapeutics, Inc. Transaction History

Capula Management LTD

  • $11.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$6.68 - $18.81 $561,099 - $1.58 Million
83,997 New
83,997 $1.43 Million
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $671,640 - $1.59 Million
134,060 New
134,060 $1.59 Million
Q3 2021

Nov 15, 2021
SELL
$21.78 - $40.45 $184,650 - $342,935
-8,478 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$32.5 - $48.96 $275,535 - $415,082
8,478 New
8,478 $329,000

Others Institutions Holding TGTX

# of Institutions
287
Shares Held
91.8M
Call Options Held
1.9M
Put Options Held
1.45M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.46B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email